Characterization of two second-site mutations preventing wild type protein aggregation caused by a dominant negative PMA1 mutant.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23825623.
- Also identified by DOI 10.1371/journal.pone.0067080 and PMC identifier 3692421.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The correct biogenesis and localization of Pma1 at the plasma membrane is essential for yeast growth. A subset of PMA1 mutations behave as dominant negative because they produce aberrantly folded proteins that form protein aggregates, which in turn provoke the aggregation of the wild type protein. One approach to understand this dominant negative effect is to identify second-site mutations able to suppress the dominant lethal phenotype caused by those mutant alleles. We isolated and characterized two intragenic second-site suppressors of the PMA1-D378T dominant negative mutation. We present here the analysis of these new mutations that are located along the amino-terminal half of the protein and include a missense mutation, L151F, and an in-frame 12bp deletion that eliminates four residues from Cys409 to Ala412. The results show that the suppressor mutations disrupt the interaction between the mutant and wild type enzymes, and this enables the wild type Pma1 to reach the plasma membrane.
Medical subject headings
- Alleles
- Mutant Proteins
- Mutation
- Protein Multimerization
- Proton-Translocating ATPases
- Saccharomyces cerevisiae Proteins